$DIM.PA

2 stories mentioning DIM.PAUpdated 26d ago

Every FINWIRES story that references DIM.PA, newest first.

AlphaValue/Baader Europe Downgrades Sartorius Stedim Biotech to Add

AlphaValue/Baader Europe on Tuesday downgraded biopharmaceutical group Sartorius Stedim Biotech (DIM.PA) to add from buy and kept the price target at 217.00 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$DIM.PA

Research58d ago

Intron Health Upgrades Sartorius Stedim Biotech to Buy Rating

Intron Health on Friday raised its rating on biopharmaceutical group Sartorius Stedim Biotech (DIM.PA) to buy from hold, while maintaining its price target at 230 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$DIM.PA

Track with the FINWIRES app suite

FolioX

Track DIM.PA in your portfolio

WheelAI

Analyze DIM.PA options with the wheel strategy

StockInsider

See market sentiment on DIM.PA